Victorian Consolidated Regulations

DRUGS, POISONS AND CONTROLLED SUBSTANCES REGULATIONS 2017 - REG 78A

    (1)     An authorised psychedelic psychiatrist must not authorise the administration of Schedule 8 MDMA or Schedule 8 psilocybine unless—

        (a)     the administration is for the medical treatment of a person other than the psychiatrist; and

        (b)     that person is under the psychiatrist's care; and

        (c)     the psychiatrist has taken all reasonable steps to ensure a therapeutic need exists for that poison; and

        (d)     the administration is authorised not merely for the purpose of supporting the drug dependence of a person; and

        (e)     the psychiatrist has taken all reasonable steps to ascertain the identity of the person to whom the poison is to be administered; and

        (f)     the psychiatrist has complied with regulation 17A.

Penalty:     100 penalty units.

    (2)     A registered medical practitioner must not authorise the administration of Schedule 8 MDMA or Schedule 8 psilocybine to a participant in a clinical trial that is approved by or notified to the Commonwealth Secretary under the Therapeutic Goods Act 1989 of the Commonwealth and     approved by a human research ethics committee unless—

        (a)     the medical practitioner is not the participant in the clinical trial; and

        (b)     the administration is for the purpose of the clinical trial; and

        (c)     the participant is under the medical practitioner's care; and

        (d)     the administration is authorised not merely for the purpose of supporting the drug dependence of the participant; and

        (e)     the medical practitioner has taken all reasonable steps to ascertain the identity of the participant to whom the poison is to be administered; and

        (f)     the medical practitioner has complied with regulation 17A.

Penalty:     100 penalty units.